Journals / Gazi Üniversitesi Fen Fakültesi Dergisi / 2020 / Cilt: 1 - Sayı: 1-2

Nörodejeneratif Hastalıkların Ca+2 Homeostazisi ile İlişkisi ve Ca+2 Homeostazisinin Düzenlenmesini Hedef Alan Doğal Bileşenler

Pages
36–50
Publication Date
2020-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Evolution of their potentials for drug candidates represents an important step for the prevention of neurodegeneration and for molecular mechanisms of Ca2+ homeostasis disorders.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neurodegenerative disorders are results of structural and functional dysfunction of the nervous system.
📊
Key Findings & Data:Calcium (Ca2+) which acts as a second messenger, is required for neuronal activity as well as for many biological activities.
💡
Conclusion & Impact:Evolution of their potentials for drug candidates represents an important step for the prevention of neurodegeneration and for molecular mechanisms of Ca2+ homeostasis disorders.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Neurodegenerative Diseases · Calcium Homeostasis · Calcium Channel

Özet

Neurodegenerative disorders are results of structural and functional dysfunction of the nervous system. Although there are several therapeutic approaches for these diseases, these approaches cannot be effective in pathological processes and are applied only palliative. For this reason, new compounds for neurodegenerative diseases are crucial. Calcium (Ca2+) which acts as a second messenger, is required for neuronal activity as well as for many biological activities. The pivotal role of Ca2+ homeostasis has long been recognized in hypertension and cardiovascular disease. Ca2+ channel blockers have been commonly prescribed for treatment of the hypertension and cardiovascular diseases because of their mechanism of action due to reducing the influx of Ca2+ . Disruptions in the intracellular Ca2+ homeostasis play a central role in the pathophysiology of neurodegenerative diseases such as Alzheimer and Parkinson. Channel blockers may be effective in neurodegenerative diseases. In this review, we aimed to review the relationship between the metabolism of neurodegenerative diseases and Ca2+ dyshomeostasis and to reveal natural compounds, which have therapeutic effects in neurodegenerative diseases, with modulation of Ca2+ homeostasis. Evolution of their potentials for drug candidates represents an important step for the prevention of neurodegeneration and for molecular mechanisms of Ca2+ homeostasis disorders.

🔖

Cite This Article

BARAN, S. S., ASLIM, B. (2020). Nörodejeneratif Hastalıkların Ca+2 Homeostazisi ile İlişkisi ve Ca+2 Homeostazisinin Düzenlenmesini Hedef Alan Doğal Bileşenler. Gazi Üniversitesi Fen Fakültesi Dergisi, Cilt: 1 - Sayı: 1-2, 36–50. https://ajindex.com/articles/852151

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hussain, G., Rasul, A., Anwar, H., Aziz, N., Razzaq, A., Wei, W., et al. (2018). Role of plant derived alkaloids and their mechanism in neurodegenerative disorders. International Journal of Biological Sciences, 14(3), 341– 357
  2. Hussain, R., Zubair, H., Pursell, S., and Shahab, M. (2018). Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches. Brain Sciences, 8(9), 177–214
  3. Yurtkap, O. and Arslan, B. (2018). Axonal transport in neurodegenerative diseases. The Journal of Neurobehavioral Sciences, 5 (2), 115–123
  4. Finberg, J. P. M. (2010). Pharmacology of rasagiline, a new mao-b inhibitor drug for the treatment of parkinson’s disease with neuroprotective potential. Rambam Maimonides Medical Journal, 1(1), e0003
  5. Korabecny, J., Zemek, F., Soukup, O., Spilovska, K., Musilek, K., Jun, D., and Kuca, K. (2014). Pharmacotherapy of Alzheimer’s disease: current state and future perspectives. Drug Design and Discovery in Alzheimer's Disease. Elsevier, 3–39
  6. Durães, F., Pinto, M., and Sousa, E. (2018). Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals, 11(2), 1–21
  7. Girdhar, S., Girdhar, A., Verma, S. K., Lather, V., Pandita, D., Ji, H. F., et al. (2015). Plant derived alkaloids in major neurodegenerative diseases: from animal models to clinical trials. Journal of Ayurvedic and Herbal Medicine, 1(3), 91–100
  8. Selkoe, D. J. (2019). Alzheimer disease and aducanumab: adjusting our approach. Nature Reviews Neurology, 15(7), 365–366
  9. Yacoubian, T. A. (2017). Neurodegenerative disorders: Why do we need new therapies? Drug discovery approaches for the treatment of neurodegenerative disorders. Academic Press., 1-16
  10. Numakawa, T., Matsumoto, T., Numakawa, Y., Richards, M., Yamawaki, S., and Kunugi, H. (2011). Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. Journal of Toxicology, 2011(405194), 12
  11. Zündorf, G. and Reiser, G. (2011). Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxidants and Redox Signaling, 14(7), 1275–1288
  12. Wu, C. L. and Wen, S. H. (2016). A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients. Medicine (United States), 95(32), 4593
  13. Schrank, S., Barrington, N., and Stutzmann, G. E. (2020). Calciu